Stocktoria
BAXTER INTERNATIONAL INC BAX
BAXTER INTERNATIONAL INC (BAX) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 3.06% (safety: safe). FY2025 revenue was $11.2B at a -8.5% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.69 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-07-31 | TD Cowen | Hold (main) |
| 2026-07-31 | Wells Fargo | Equal-Weight (main) |
| 2026-07-31 | Stifel | Hold (main) |
| 2026-07-31 | Citigroup | Neutral (up) |
| 2026-07-28 | UBS | Neutral (main) |
| 2026-07-28 | Stifel | Hold (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Forward estimates · earnings calendar →
Consensus analyst estimates and scheduled dates — forward-looking, may change.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.195 |
| Retained earnings / assets | 0.683 |
| EBIT / assets | -0.015 |
| Equity / liabilities | 0.439 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| BAX | BAXTER INTERNATIONAL INC | 5/9 | 3.86 | — | +5.7% |
| SOLV | Solventum Corp | 6/9 | 2.34 | 8.9 | +0.9% |
| RMD | RESMED INC | 8/9 | 8.65 | 20.7 | +9.8% |
| DXCM | DEXCOM INC | 7/9 | 4.98 | 32.4 | +15.6% |
| MMED | MiniMed Group, Inc. | 3/9 | 4.28 | — | +14.3% |
| WST | WEST PHARMACEUTICAL SERVICES INC | 7/9 | 9.34 | 47.2 | +6.3% |
| GMED | GLOBUS MEDICAL INC | 7/9 | 10.06 | 21.8 | +16.7% |
About BAXTER INTERNATIONAL INC
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
FAQ
Is BAX financially healthy?
BAXTER INTERNATIONAL INC's Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does BAX pay a dividend, and is it safe?
Yes. BAXTER INTERNATIONAL INC pays a dividend yielding about 3.06% with a -36.4% payout ratio, rated “safe” for safety.
How profitable is BAX?
In FY2025, BAXTER INTERNATIONAL INC had a net margin of -8.5% and a return on equity of -15.6%.
Is BAX overvalued or undervalued?
BAXTER INTERNATIONAL INC trades at about 5.2× trailing earnings — below its 10-year norm (10-year range 5.3×–66.7×, median 25.6×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for BAX?
The average Wall-Street price target for BAXTER INTERNATIONAL INC is $28.73, about 6.6% above the recent price, from 11 analysts (consensus: hold).
Is BAX a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on BAXTER INTERNATIONAL INC: a Piotroski F-score of 5/9, an Altman Z″ in the safe zone, a dividend yield of 3.06%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.